Circ MedTech

Circ MedTech was an Israeli medical device company headquartered in Herzliya, Israel, that operated from 2009 to 2019. The company was known for developing PrePex, a non-surgical male circumcision device designed to help prevent HIV transmission in Africa.

Founded by Dr. Oren Fuerst, Tzameret Fuerst, Ido Kilemnick, and Shaul Shohat, the company emerged in response to a 2007 United Nations and World Health Organization (WHO) initiative promoting male circumcision to reduce HIV infection rates. PrePex received FDA approval in 2012 and WHO prequalification in 2016, with the device being used in multiple African countries.

Despite initial success and reported sales of 1.5 million units, the company ceased operations in 2019 following WHO concerns about increased tetanus risk associated with the device. The company claimed based on WHO statistics regarding circumcision and AIDS prevention, that its PrePex device had saved an estimated 250,000 lives during its period of use. Provided by Wikipedia
Showing 1 - 1 results of 1 for search 'Shaul Shohat', query time: 0.01s Refine Results
  1. 1
    Assessment of Bioprotect's Biodegradable Balloon System as a Rectal Spacer in Radiotherapy: An Animal Study on Tissue Response and Biocompatibility

    Assessment of Bioprotect's Biodegradable Balloon System as a Rectal Spacer in Radiotherapy: An Animal Study on Tissue Response and Biocompatibility by Yuval Ramot, Tal Levin-Harrus, Adva Ezratty, Michal Steiner, Nati Ezov, Abraham J. Domb, Muhammad Abdel-Haq, Shaul Shohat, Liron Aperman, Lee Adler, Oleg Dolkart, Abraham Nyska

    Published 2023
    Connect to this object online.
    Book
    Save to List
    Saved in:

Search Tools: